Gilead Sciences, Inc. GILD on Wednesday, announced the pricing of
senior unsecured notes in an aggregate principal amount of $10 billion,
in an underwritten, registered public offering, consisting of six
tranches:
$1,000 million of 1.850% senior notes maturing in 2018
$2,000 million of 2.550% senior notes maturing in 2020
$1,000 million of 3.250% senior notes maturing in 2022
$2,750 million of 3.650% senior notes maturing in 2026
$1,000 million of 4.600% senior
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in